1. Home
  2. SXTP vs RELI Comparison

SXTP vs RELI Comparison

Compare SXTP & RELI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SXTP
  • RELI
  • Stock Information
  • Founded
  • SXTP 2010
  • RELI 2013
  • Country
  • SXTP United States
  • RELI United States
  • Employees
  • SXTP N/A
  • RELI N/A
  • Industry
  • SXTP Biotechnology: Pharmaceutical Preparations
  • RELI Specialty Insurers
  • Sector
  • SXTP Health Care
  • RELI Finance
  • Exchange
  • SXTP Nasdaq
  • RELI Nasdaq
  • Market Cap
  • SXTP 2.7M
  • RELI 3.0M
  • IPO Year
  • SXTP 2023
  • RELI N/A
  • Fundamental
  • Price
  • SXTP $2.47
  • RELI $1.22
  • Analyst Decision
  • SXTP Hold
  • RELI
  • Analyst Count
  • SXTP 1
  • RELI 0
  • Target Price
  • SXTP N/A
  • RELI N/A
  • AVG Volume (30 Days)
  • SXTP 186.6K
  • RELI 54.9K
  • Earning Date
  • SXTP 05-15-2025
  • RELI 05-14-2025
  • Dividend Yield
  • SXTP N/A
  • RELI N/A
  • EPS Growth
  • SXTP N/A
  • RELI N/A
  • EPS
  • SXTP N/A
  • RELI N/A
  • Revenue
  • SXTP $802,323.00
  • RELI $14,208,143.00
  • Revenue This Year
  • SXTP $95.50
  • RELI N/A
  • Revenue Next Year
  • SXTP $80.78
  • RELI N/A
  • P/E Ratio
  • SXTP N/A
  • RELI N/A
  • Revenue Growth
  • SXTP 118.37
  • RELI 2.40
  • 52 Week Low
  • SXTP $1.41
  • RELI $0.97
  • 52 Week High
  • SXTP $36.00
  • RELI $18.53
  • Technical
  • Relative Strength Index (RSI)
  • SXTP 50.12
  • RELI 55.58
  • Support Level
  • SXTP $2.10
  • RELI $1.01
  • Resistance Level
  • SXTP $2.47
  • RELI $1.33
  • Average True Range (ATR)
  • SXTP 0.24
  • RELI 0.09
  • MACD
  • SXTP -0.04
  • RELI 0.02
  • Stochastic Oscillator
  • SXTP 46.84
  • RELI 65.63

About SXTP 60 Degrees Pharmaceuticals Inc.

60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases.

About RELI Reliance Global Group Inc.

Reliance Global Group Inc operates as a holding company with diversified interests in the insurance market, as well as other related sectors. The company focuses on growing by pursuing acquisition strategies, initially and focused on wholesale and retail insurance agencies. Its primary strategies is to identify specific risks to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows. The company generates revenue in the form of commissions.

Share on Social Networks: